Net Profit Margin
since 2005
Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Reportable Segments
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Edwards Lifesciences Corp., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | = | 100 | × | ÷ | |||
| Dec 31, 2020 | = | 100 | × | ÷ | |||
| Dec 31, 2019 | = | 100 | × | ÷ | |||
| Dec 31, 2018 | = | 100 | × | ÷ | |||
| Dec 31, 2017 | = | 100 | × | ÷ | |||
| Dec 31, 2016 | = | 100 | × | ÷ | |||
| Dec 31, 2015 | = | 100 | × | ÷ | |||
| Dec 31, 2014 | = | 100 | × | ÷ | |||
| Dec 31, 2013 | = | 100 | × | ÷ | |||
| Dec 31, 2012 | = | 100 | × | ÷ | |||
| Dec 31, 2011 | = | 100 | × | ÷ | |||
| Dec 31, 2010 | = | 100 | × | ÷ | |||
| Dec 31, 2009 | = | 100 | × | ÷ | |||
| Dec 31, 2008 | = | 100 | × | ÷ | |||
| Dec 31, 2007 | = | 100 | × | ÷ | |||
| Dec 31, 2006 | = | 100 | × | ÷ | |||
| Dec 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial data reflects several key trends in the company's performance over the period from 2005 to 2021. Net sales demonstrate a consistent upward trajectory, increasing steadily from approximately $998 million in 2005 to over $5.2 billion in 2021. This indicates sustained revenue growth throughout the years.
Net income exhibits a general growth trend as well, albeit with some fluctuations. Starting at $79.3 million in 2005, net income rose gradually, with notable jumps in certain years. Significant increases are observed in 2009, reaching $229.1 million, and again in 2014 at $811.1 million, followed by a dip in 2015 and 2016, before rising sharply to $1.5 billion in 2021. These variations suggest periods of enhanced profitability possibly linked to operational improvements or market conditions.
The net profit margin percentage, which measures profitability relative to sales, follows a generally positive trend with some volatility. It begins at 7.95% in 2005, peaks at an exceptionally high 34.92% in 2014, then somewhat normalizes ranging between approximately 16% and 28% in the later years. The 2014 peak signifies an unusually high-profit efficiency during that year, while subsequent years maintain strong but more moderate margins, illustrating effective cost control and profitability management.
- Revenue Growth
- Net sales nearly quintupled over the period, indicating robust expansion in the company's market reach and/or product demand.
- Profitability Trends
- Net income growth aligns with sales increases but shows more variability, highlighting periods of either higher operational costs, investments, or one-time events impacting earnings.
- Profit Margin Fluctuations
- Profit margins vary significantly year-over-year, with a standout peak in 2014 suggesting an exceptional operational year. Overall margins remain strong, underscoring good profitability management despite fluctuations.
In summary, the data depicts a company that has progressively expanded its revenue base with improving profitability over the long term, despite some volatility in net income and profit margins. This suggests a resilient business model capable of sustaining growth and generating healthy returns on sales.
Comparison to Competitors
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Dec 31, 2014 | ||||||
| Dec 31, 2013 | ||||||
| Dec 31, 2012 | ||||||
| Dec 31, 2011 | ||||||
| Dec 31, 2010 | ||||||
| Dec 31, 2009 | ||||||
| Dec 31, 2008 | ||||||
| Dec 31, 2007 | ||||||
| Dec 31, 2006 | ||||||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).